Rhode Island Hospital Receives $10.8 Million Award to Continue Research in Joint Health
Published on September 14, 2012
Rhode Island Hospital has received a $10.8 million award from the National Institutes of Health for the second phase of a study into cartilage and joint diseases. The grant, one of the largest in the hospital's history, has been awarded to the Center of Biomedical Research Excellence (COBRE) in Skeletal Health and Repair and supports the second phase of research, building on a Phase I grant awarded in 2007 for $11 million.
Dr. Michael Ehrlich, chief of the department of orthopedics at Rhode Island Hospital and Miriam Hospital, said that the grant would spur new business development through the development of patents for the research. A new angel group of private investors is being created to fund the development of new companies based on the research, Ehrlich said.
There are an estimated 46 million people in the United States with cartilage and joint diseases, often termed arthritis. In Rhode Island, 33 percent of men and 25 percent of women, compared to national figures of 24 percent of women and 18 percent of men, have cartilage and joint disease.
Learn more about the COBRE for Skeletal Health and Repair